USA500, Daily
US equities have opened positively and the USA500 moved back to the key 61.8 Fibonacci level of the March 23 low. Overnight gains have extended higher after Moderna shares surged following the company’s report of positive data for an experimental coronavirus vaccine. Stocks were already in rally mode before Moderna’s announcement, keying off upbeat comments from Fed Chair Powell and ECB chief economist Lane over the weekend. Optimism over the ability of economies to restart has also supported. Powell said the Fed is not out of ammunition and could do more, while warning that he wouldn’t bet against the US economy neither in the short nor the long run.
The S&P500 is up 2.4%, the Dow has climbed 3.0% to 24,356 and the NASDAQ has firmed 1.7% and opened at 9,167. European bourses are well into the green too, with the Euro Stoxx 3.7% higher, Germany’s DAX jumping 4.2% and France’s CAC 40 up 3.8%. The UK’s FTSE 100 has risen 3.1%. Asian shares saw mild gains, with China’s CSI 300 edging up 0.3% and Hong Kong’s Hang Seng improving 0.6%. Japan’s Nikkei 225 rose 0.5%, assisted by a less severe than anticipated drop in Q1 GDP.
Levels to watch on the USA500 include; 50.0 Fibonacci level (2,800), 50-day moving average (2,700) and beyond the 61.8 Fibonacci level is the 200-day moving average and psychological round number 3,000.
Click here to access the HotForex Economic Calendar
Stuart Cowell
Head Market Analyst
Disclaimer: This material is provided as a general marketing communication for information purposes only and does not constitute an independent investment research. Nothing in this communication contains, or should be considered as containing, an investment advice or an investment recommendation or a solicitation for the purpose of buying or selling of any financial instrument. All information provided is gathered from reputable sources and any information containing an indication of past performance is not a guarantee or reliable indicator of future performance. Users acknowledge that any investment in Leveraged Products is characterized by a certain degree of uncertainty and that any investment of this nature involves a high level of risk for which the users are solely responsible and liable. We assume no liability for any loss arising from any investment made based on the information provided in this communication. This communication must not be reproduced or further distributed without our prior written permission.
